-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Ey1Ft8fi8vbyBHpkWqnfqlc0uZ2ue7bU9W8wQzaOhMNcHOlsAtLwST3X5gZuATb+ 3SIgYSdMWCJzCsgxjo1DNw== 0000950162-05-000433.txt : 20050419 0000950162-05-000433.hdr.sgml : 20050419 20050419150109 ACCESSION NUMBER: 0000950162-05-000433 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20050418 FILED AS OF DATE: 20050419 DATE AS OF CHANGE: 20050419 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SCICLONE PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000880771 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943116852 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 901 MARINER'S ISLAND BLVD. STREET 2: SUITE 205 CITY: SAN MATEO STATE: CA ZIP: 94404 BUSINESS PHONE: 650-358-3456 MAIL ADDRESS: STREET 1: 901 MARINER'S ISLAND BLVD. STREET 2: SUITE 205 CITY: SAN MATEO STATE: CA ZIP: 94404 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CAVAZZA CLAUDIO CENTRAL INDEX KEY: 0001164803 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19825 FILM NUMBER: 05759074 MAIL ADDRESS: STREET 1: VIA SUDAFRICA 20 CITY: ROME ITALY STATE: L6 ZIP: 00000 4 1 claudioform4-041905_ex.xml X0202 4 2005-04-18 0 0000880771 SCICLONE PHARMACEUTICALS INC SCLN 0001164803 CAVAZZA CLAUDIO VIA SUDAFRICA, 20 ROME L6 ITALY 0 0 1 0 Common Stock 2005-04-18 4 P 0 481 2.70 A 3537858 I I Common Stock 2005-04-18 4 P 0 0 0 A 394615 D Shares directly owned by Defiante Farmaceutica, L.D.A. ("Defiante"). Defiante is 58% directly owned by Sigma Tau Finanzaria S.p.A. ("Sigma Tau") and 42% directly owned by Sigma Tau's wholly-owned subsidiary, Sigma Tau International S.A. Claudio Cavazza directly and indirectly owns 60% of Sigma Tau. N/A. /s/ Maurizio Terenzi, Maurizio Terenzi, Attorney-In-Fact 2005-04-19 -----END PRIVACY-ENHANCED MESSAGE-----